Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

A Randomized Trial of Zoledronic Acid to Prevent Bone Loss in the First Year after Kidney Transplantation.

Marques IDB, Araújo MJCLN, Graciolli FG, Dos Reis LM, Pereira RMR, Alvarenga JC, Custódio MR, Jorgetti V, Elias RM, Moysés RMA, David-Neto E.

J Am Soc Nephrol. 2019 Jan 3. pii: ASN.2018060656. doi: 10.1681/ASN.2018060656. [Epub ahead of print]

PMID:
30606784
2.

The trabecular bone score: Relationships with trabecular and cortical microarchitecture measured by HR-pQCT and histomorphometry in patients with chronic kidney disease.

Ramalho J, Marques IDB, Hans D, Dempster D, Zhou H, Patel P, Pereira RMR, Jorgetti V, Moyses RMA, Nickolas TL.

Bone. 2018 Nov;116:215-220. doi: 10.1016/j.bone.2018.08.006. Epub 2018 Aug 8.

PMID:
30098418
3.

The effect of vitamin D and zoledronic acid in bone marrow adiposity in kidney transplant patients: A post hoc analysis.

Hernandez MJ, Dos Reis LM, Marques ID, Araujo MJ, Truyts CAM, Oliveira IB, Barreto FC, David-Neto E, Custodio MR, Moyses RM, Bellorin-Font E, Jorgetti V.

PLoS One. 2018 May 25;13(5):e0197994. doi: 10.1371/journal.pone.0197994. eCollection 2018.

4.

Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities.

Marques ID, Araújo MJ, Graciolli FG, Reis LM, Pereira RM, Custódio MR, Jorgetti V, Elias RM, David-Neto E, Moysés RM.

Osteoporos Int. 2017 May;28(5):1675-1683. doi: 10.1007/s00198-017-3956-9. Epub 2017 Feb 16.

PMID:
28204954
5.

[Scientists in cartoons: humanizing science].

Fioravanti CH, Andrade RO, Marques ID.

Hist Cienc Saude Manguinhos. 2016 Oct-Dec;23(4):1191-1208. doi: 10.1590/S0104-59702016000400008. Portuguese.

6.

Electrochemical behavior of bioactive coatings on cp-Ti surface for dental application.

Marques ID, Barão VA, da Cruz NC, Yuan JC, Mesquita MF, Ricomini-Filho AP, Sukotjo C, Mathew MT.

Corros Sci. 2015 Nov 1;100:133-146.

7.

Tribocorrosion behavior of biofunctional titanium oxide films produced by micro-arc oxidation: Synergism and mechanisms.

Marques IDSV, Alfaro MF, Cruz NCD, Mesquita MF, Takoudis C, Sukotjo C, Mathew MT, Barão VAR.

J Mech Behav Biomed Mater. 2016 Jul;60:8-21. doi: 10.1016/j.jmbbm.2015.12.030. Epub 2015 Dec 30.

PMID:
26773646
8.

Outcomes and Mortality in Renal Transplant Recipients Admitted to the Intensive Care Unit.

Marques ID, Caires RA, Machado DJ, Goldenstein PT, Rodrigues CE, Pegas JC, de Paula FJ, David-Neto E, Costa MC.

Transplant Proc. 2015 Nov;47(9):2694-9. doi: 10.1016/j.transproceed.2015.07.035.

PMID:
26680074
9.

Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease.

de Oliveira RA, Barreto FC, Mendes M, dos Reis LM, Castro JH, Britto ZM, Marques ID, Carvalho AB, Moysés RM, Jorgetti V.

Kidney Int. 2015 May;87(5):1039-45. doi: 10.1038/ki.2014.372. Epub 2014 Dec 10.

PMID:
25493951
10.

Rituximab in a B cell-driven regimen for the treatment of recurrent membranoproliferative glomerulonephritis after kidney transplantation.

Marques ID, Ramalho J, David DR, Nahas WC, David-Neto E.

Int Urol Nephrol. 2014 Oct;46(10):2053-4. doi: 10.1007/s11255-014-0792-0. Epub 2014 Jul 31. No abstract available.

PMID:
25080208
11.

[Vasculopathy in the kidney allograft at time of transplantation delays recovery of graft function after deceased-donor kidney transplantation].

Marques ID, Repizo LP, Pontelli R, de Paula FJ, Nahas WC, David DS, Neto ED, Lemos FB.

J Bras Nefrol. 2014 Jan-Mar;36(1):54-8. Portuguese.

12.

Rejection-triggered haemophagocytic syndrome in renal transplantation successfully treated with intravenous immunoglobulin.

Marques ID, Caires RA, de Paula FJ, Nahas WC, David-Neto E.

Clin Kidney J. 2013 Oct;6(5):530-2. doi: 10.1093/ckj/sft077. Epub 2013 Aug 1.

13.

Clinical features and outcomes of tuberculosis in kidney transplant recipients in Brazil: a report of the last decade.

Marques ID, Azevedo LS, Pierrotti LC, Caires RA, Sato VA, Carmo LP, Ferreira GF, Gamba C, de Paula FJ, Nahas WC, David-Neto E.

Clin Transplant. 2013 Mar-Apr;27(2):E169-76. doi: 10.1111/ctr.12077. Epub 2013 Jan 28.

PMID:
23351041
14.

De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.

Caires RA, Marques ID, Repizo LP, Sato VA, Carmo LP, Machado DJ, de Paula FJ, Nahas WC, David-Neto E.

Transplant Proc. 2012 Oct;44(8):2388-90. doi: 10.1016/j.transproceed.2012.07.039.

PMID:
23026601
15.

Lupus nephritis is more severe in children and adolescents than in older adults.

Sato VA, Marques ID, Goldenstein PT, Carmo LP, Jorge LB, Titan SM, Barros RT, Woronik V.

Lupus. 2012 Aug;21(9):978-83. doi: 10.1177/0961203312443421. Epub 2012 Mar 26.

PMID:
22451604
16.

[Ten-year follow-up of kidney transplantation with living unrelated donor].

Ferreira GF, Marques ID, Park CH, Machado DJ, Lemos FB, Paula FJ, Nahas WC, David-Neto E.

J Bras Nefrol. 2011 Jul-Sep;33(3):345-50. Portuguese.

17.

Brainstem tumour mimicking pheochromocytoma.

Melo NC, Carmo LP, Rodrigues CE, Marques ID, Praxedes JN.

J Hum Hypertens. 2009 Jul;23(7):493-4. doi: 10.1038/jhh.2009.3. Epub 2009 Feb 12. No abstract available.

PMID:
19279662
18.

Electrolyte disturbances and acute kidney injury induced by imatinib therapy.

de Oliveira RA, Marques ID, Seguro AC, Andrade L.

NDT Plus. 2009 Feb;2(1):27-9. doi: 10.1093/ndtplus/sfn188. Epub 2008 Dec 4.

19.

[Hemophagocytic Syndrome: a clinical presentation of systemic lupus erythematosus].

Silva Dda F, Anunciação FA, Arcoverde Jda C, Costa LP, Marques ID, Pinheiro Gda S, Moreira Mdo S.

Acta Reumatol Port. 2008 Jan-Mar;33(1):91-7. Review. Portuguese.

Supplemental Content

Loading ...
Support Center